Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Gilead targets remdesivir supply for two million COVID-19 patients by year-end
The company also said it hoped to start trials in August of an easier-to-use inhaled version of the medicine, currently…
Bayer close to glyphosate settlement worth $8-10 billion: German business daily
The settlement is over claims that its glyphosate-based Roundup weedkiller causes cancer
Pharma industry appreciates CBIC’s move to adopts paperless process
The digital adoption is being carried out in a phased manner the first phase of faceless assessment started in Chennai and…
Elemental Impurity Analysis in Pharmaceuticals: Validating performance of an Agilent 7800 ICP MS
Worldwide, regulatory authorities are responsible for ensuring that pharmaceutical products are both effective and safe. To…
West Launches AccelTRA® RTS/RTU Product Line in India
The AccelTRA components program was designed to provide generic drug manufacturers with components for injectable drug delivery…
Inovio gets $71 million from US defense department for COVID-19 vaccine device
Inovio, which began human testing of its vaccine in April, said it expects to report interim results from the trial later this…
Industry should come forward to develop Pharma and Medical Devices parks: Mansukh Mandaviya
He made the statement while addressing the launch webinar of India’s first virtual exhibition and conference, ‘Virtual Healthcare…
Trials with Oxford COVID-19 vaccine start in Brazil
Trials will count on 2,000 health workers volunteers in Sao Paulo and 1,000 people in Rio de Janeiro
Gilead to commence trials of inhaled remdesivir
The CEO informs that the company aims to enable easier administration outside the hospital at earlier stages of the disease with…
Indian ancillary manufacturers assure uninterrupted supply of materials related to COVID-19 vaccine
In the recent past, many, globally and in India, had raised concerns about a potential shortage of ancillary supplies to…